173 related articles for article (PubMed ID: 17907013)
1. Psoriasis of the face and flexures.
van de Kerkhof PC; Murphy GM; Austad J; Ljungberg A; Cambazard F; Duvold LB
J Dermatolog Treat; 2007; 18(6):351-60. PubMed ID: 17907013
[TBL] [Abstract][Full Text] [Related]
2. Topical Therapies in Psoriasis.
Torsekar R; Gautam MM
Indian Dermatol Online J; 2017; 8(4):235-245. PubMed ID: 28761838
[TBL] [Abstract][Full Text] [Related]
3. Childhood guttate psoriasis: an updated review.
Leung AK; Barankin B; Lam JM; Leong KF
Drugs Context; 2023; 12():. PubMed ID: 37908643
[TBL] [Abstract][Full Text] [Related]
4. Biogeography and environmental conditions shape bacteriophage-bacteria networks across the human microbiome.
Hannigan GD; Duhaime MB; Koutra D; Schloss PD
PLoS Comput Biol; 2018 Apr; 14(4):e1006099. PubMed ID: 29668682
[TBL] [Abstract][Full Text] [Related]
5. Dynamic Role of Host Stress Responses in Modulating the Cutaneous Microbiome: Implications for Wound Healing and Infection.
Holmes CJ; Plichta JK; Gamelli RL; Radek KA
Adv Wound Care (New Rochelle); 2015 Jan; 4(1):24-37. PubMed ID: 25566412
[No Abstract] [Full Text] [Related]
6. Tuning of skin immunity by skin commensal bacteria.
Kosiewicz MM; Zirnheld AL; Alard P
Immunotherapy; 2013 Jan; 5(1):23-5. PubMed ID: 23256795
[TBL] [Abstract][Full Text] [Related]
7. The concept of the acid mantle of the skin: its relevance for the choice of skin cleansers.
Schmid MH; Korting HC
Dermatology; 1995; 191(4):276-80. PubMed ID: 8573921
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy of biologics versus conventional systemic therapies in the treatment of psoriasis at a comprehensive psoriasis care center.
Au SC; Madani A; Alhaddad M; Alkofide M; Gottlieb AB
J Drugs Dermatol; 2013 Aug; 12(8):861-6. PubMed ID: 23986158
[TBL] [Abstract][Full Text] [Related]
9. Psoriasis treatment in difficult locations: scalp, nails, and intertriginous areas.
Wozel G
Clin Dermatol; 2008; 26(5):448-59. PubMed ID: 18755363
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials.
Schmitt J; Zhang Z; Wozel G; Meurer M; Kirch W
Br J Dermatol; 2008 Sep; 159(3):513-26. PubMed ID: 18627372
[TBL] [Abstract][Full Text] [Related]
11. Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter cross-sectional study in Germany.
Augustin M; Krüger K; Radtke MA; Schwippl I; Reich K
Dermatology; 2008; 216(4):366-72. PubMed ID: 18319601
[TBL] [Abstract][Full Text] [Related]
12. Underdiagnosed and undertreated psoriasis: Nuances of treating psoriasis affecting the scalp, face, intertriginous areas, genitals, hands, feet, and nails.
Merola JF; Qureshi A; Husni ME
Dermatol Ther; 2018 May; 31(3):e12589. PubMed ID: 29512290
[TBL] [Abstract][Full Text] [Related]
13. Facial involvement and the severity of psoriasis.
Passos AN; de A Rêgo VRP; Duarte GV; Santos E Miranda RC; de O Rocha B; de F S P de Oliveira M
Int J Dermatol; 2019 Nov; 58(11):1300-1304. PubMed ID: 31347152
[TBL] [Abstract][Full Text] [Related]
14. Treatments for inverse psoriasis: a systematic review.
Reynolds KA; Pithadia DJ; Lee EB; Wu JJ
J Dermatolog Treat; 2020 Dec; 31(8):786-793. PubMed ID: 31100992
[No Abstract] [Full Text] [Related]
15. Psoriasis in special localizations.
Dopytalska K; Sobolewski P; Błaszczak A; Szymańska E; Walecka I
Reumatologia; 2018; 56(6):392-398. PubMed ID: 30647487
[TBL] [Abstract][Full Text] [Related]
16. Why Biologics and Biosimilars Remain So Expensive: Despite Two Wins for Biosimilars, the Supreme Court's Recent Rulings do not Solve Fundamental Barriers to Competition.
Chen BK; Yang YT; Bennett CL
Drugs; 2018 Nov; 78(17):1777-1781. PubMed ID: 30446980
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of psoriasis in hard-to-treat body locations: data from the Danish skin cohort.
Egeberg A; See K; Garrelts A; Burge R
BMC Dermatol; 2020 May; 20(1):3. PubMed ID: 32434510
[TBL] [Abstract][Full Text] [Related]
18. Genital psoriasis: A systematic literature review on this hidden skin disease.
Meeuwis KA; de Hullu JA; Massuger LF; van de Kerkhof PC; van Rossum MM
Acta Derm Venereol; 2011 Jan; 91(1):5-11. PubMed ID: 20927490
[TBL] [Abstract][Full Text] [Related]
19. Multimorbidity of Psoriasis: A Large-Scale Population Study of Its Associated Comorbidities.
Almenara-Blasco M; Gracia-Cazaña T; Poblador-Plou B; Laguna-Berna C; Carmona-Pírez J; Navarro-Bielsa A; Prados-Torres A; Gimeno-Miguel A; Gilaberte Y
J Clin Med; 2024 Jan; 13(2):. PubMed ID: 38256625
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness of biologics for patients with moderate-to-severe psoriasis and special area involvement: week 12 results from the observational Psoriasis Study of Health Outcomes (PSoHO).
Piaserico S; Riedl E; Pavlovsky L; Vender RB; Mert C; Tangsirisap N; Haustrup N; Gallo G; Schuster C; Brunner PM
Front Med (Lausanne); 2023; 10():1185523. PubMed ID: 37457564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
